Near-infrared light triggered in situ release of CO for enhanced therapy of glioblastoma

Abstract Background Photodynamic therapy (PDT) features high biocompatibility and high spatiotemporal selectivity, showing a great potential in glioblastoma (GBM) treatment. However, its application was restricted by the poor therapeutic efficacy and side effect. Results In this study, a therapeutic...

Full description

Saved in:
Bibliographic Details
Main Authors: Juan Ge, Miaomiao Zuo, Qirong Wang, Zhen Li
Format: Article
Language:English
Published: BMC 2023-02-01
Series:Journal of Nanobiotechnology
Subjects:
Online Access:https://doi.org/10.1186/s12951-023-01802-9
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1823861620643725312
author Juan Ge
Miaomiao Zuo
Qirong Wang
Zhen Li
author_facet Juan Ge
Miaomiao Zuo
Qirong Wang
Zhen Li
author_sort Juan Ge
collection DOAJ
description Abstract Background Photodynamic therapy (PDT) features high biocompatibility and high spatiotemporal selectivity, showing a great potential in glioblastoma (GBM) treatment. However, its application was restricted by the poor therapeutic efficacy and side effect. Results In this study, a therapeutic nanoplatform (UCNPs@Ce6/3HBQ@CM) with combination of PDT and CO therapy was constructed, in which a photoCORM and a photosensitizer were loaded onto the surface of upconversion nanoparticles (UCNPs) functioning as photon transducer. Benefitting from NIR excitation and multicolor emission of UCNPs, the penetration depth of excitation light is enhanced and meanwhile simultaneous generation of CO and ROS in tumor site can be achieved. The as-prepared nanocomposite possessed an elevated therapeutic efficiency with the assistance of CO through influencing mitochondrial respiration and depleting ATP, accompanying with the reduced inflammatory responses. By wrapping a homologous cell membrane, the nanocomposite can target GBM and accumulate in the tumor site, affording a powerful tool for precise and efficient treatment of GBM. Conclusion This therapeutic nanoplatform UCNPs@Ce6/3HBQ@CM, which combines PDT and CO therapy enables precise and efficient treatment of refractory glioblastoma.
format Article
id doaj-art-1b2a2c2342d4462ca42fbe6088a14166
institution Kabale University
issn 1477-3155
language English
publishDate 2023-02-01
publisher BMC
record_format Article
series Journal of Nanobiotechnology
spelling doaj-art-1b2a2c2342d4462ca42fbe6088a141662025-02-09T12:52:54ZengBMCJournal of Nanobiotechnology1477-31552023-02-0121111510.1186/s12951-023-01802-9Near-infrared light triggered in situ release of CO for enhanced therapy of glioblastomaJuan Ge0Miaomiao Zuo1Qirong Wang2Zhen Li3College of Health Science and Engineering, College of Chemistry and Chemical Engineering, Hubei UniversityCollege of Health Science and Engineering, College of Chemistry and Chemical Engineering, Hubei UniversityCollege of Health Science and Engineering, College of Chemistry and Chemical Engineering, Hubei UniversityCollege of Health Science and Engineering, College of Chemistry and Chemical Engineering, Hubei UniversityAbstract Background Photodynamic therapy (PDT) features high biocompatibility and high spatiotemporal selectivity, showing a great potential in glioblastoma (GBM) treatment. However, its application was restricted by the poor therapeutic efficacy and side effect. Results In this study, a therapeutic nanoplatform (UCNPs@Ce6/3HBQ@CM) with combination of PDT and CO therapy was constructed, in which a photoCORM and a photosensitizer were loaded onto the surface of upconversion nanoparticles (UCNPs) functioning as photon transducer. Benefitting from NIR excitation and multicolor emission of UCNPs, the penetration depth of excitation light is enhanced and meanwhile simultaneous generation of CO and ROS in tumor site can be achieved. The as-prepared nanocomposite possessed an elevated therapeutic efficiency with the assistance of CO through influencing mitochondrial respiration and depleting ATP, accompanying with the reduced inflammatory responses. By wrapping a homologous cell membrane, the nanocomposite can target GBM and accumulate in the tumor site, affording a powerful tool for precise and efficient treatment of GBM. Conclusion This therapeutic nanoplatform UCNPs@Ce6/3HBQ@CM, which combines PDT and CO therapy enables precise and efficient treatment of refractory glioblastoma.https://doi.org/10.1186/s12951-023-01802-9Carbon monoxidePhotodynamic therapyAnti-inflammatoryUpconversion nanoparticlesGlioblastoma
spellingShingle Juan Ge
Miaomiao Zuo
Qirong Wang
Zhen Li
Near-infrared light triggered in situ release of CO for enhanced therapy of glioblastoma
Journal of Nanobiotechnology
Carbon monoxide
Photodynamic therapy
Anti-inflammatory
Upconversion nanoparticles
Glioblastoma
title Near-infrared light triggered in situ release of CO for enhanced therapy of glioblastoma
title_full Near-infrared light triggered in situ release of CO for enhanced therapy of glioblastoma
title_fullStr Near-infrared light triggered in situ release of CO for enhanced therapy of glioblastoma
title_full_unstemmed Near-infrared light triggered in situ release of CO for enhanced therapy of glioblastoma
title_short Near-infrared light triggered in situ release of CO for enhanced therapy of glioblastoma
title_sort near infrared light triggered in situ release of co for enhanced therapy of glioblastoma
topic Carbon monoxide
Photodynamic therapy
Anti-inflammatory
Upconversion nanoparticles
Glioblastoma
url https://doi.org/10.1186/s12951-023-01802-9
work_keys_str_mv AT juange nearinfraredlighttriggeredinsitureleaseofcoforenhancedtherapyofglioblastoma
AT miaomiaozuo nearinfraredlighttriggeredinsitureleaseofcoforenhancedtherapyofglioblastoma
AT qirongwang nearinfraredlighttriggeredinsitureleaseofcoforenhancedtherapyofglioblastoma
AT zhenli nearinfraredlighttriggeredinsitureleaseofcoforenhancedtherapyofglioblastoma